MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells

Triple-negative breast cancer (TNBC) has the highest percentage of lymphocytic infiltration among breast cancer subtypes, and TNBC patients may benefit from anti-PD-1/PD-L1 immunotherapy. However, some cases whether the immune checkpoint blockade (ICB) shows low targeting efficiency have occurred an...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xianxian, Xie, Yu, Yu, Jing, Hu, Xiao, Liu, Zhanzhao, Li, Ning, Qin, Junfang, Lan, Lan, Yuan, Mengci, Pan, Zhanyu, Wang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529401/
https://www.ncbi.nlm.nih.gov/pubmed/36199799
http://dx.doi.org/10.1155/2022/3659714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529401/
https://www.ncbi.nlm.nih.gov/pubmed/36199799
http://dx.doi.org/10.1155/2022/3659714

Ejemplares similares